International Biotechnology Trust PLC Oric Pharmaceuticals, Inc. Transaction History

International Biotechnology Trust PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$2.7 - $7.07 $475,785 - $1.25 Million	-176,217 Closed	0 $0
Q1 2022 May 20, 2022	BUY	$4.54 - $16.1 $105,405 - $373,793	23,217 Added 15.17%	176,217 $940,000
Q4 2021 Feb 15, 2022	BUY	$12.01 - $20.3 $1.2 Million - $2.03 Million	100,000 Added 188.68%	153,000 $2.25 Million
Q4 2020 Feb 19, 2021	BUY	$20.32 - $39.8 $1.08 Million - $2.11 Million	53,000 New	53,000 $1.79 Million

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.